Roivant Sciences (ROIV) Gross Profit (2020 - 2026)

Roivant Sciences (ROIV) has reported Gross Profit for 7 consecutive years, with $1.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit fell 42.56% year-over-year to $1.2 million; the trailing twelve-month figure through Jun 2026 stood at $9.4 million (down 72.97% YoY), and the FY2026 full-year result was $7.0 million, down 75.21% from the prior year.
• Gross Profit slipped to $1.2 million in Q2 2026 per ROIV's latest filing, from $4.8 million in the prior quarter.
• Across five years, Gross Profit topped out at $25.0 million in Q4 2022 and bottomed at $1.2 million in Q2 2026.
• Historically, Gross Profit has averaged $9.4 million across 5 years, with a median of $4.8 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Gross Profit soared 571.42% in 2023, then sank 77.02% in 2025.
• Over 5 years, Gross Profit stood at $25.0 million in 2022, then decreased by 10.66% to $22.3 million in 2023, then declined by 6.79% to $20.8 million in 2024, then tumbled by 77.02% to $4.8 million in 2025, then plunged by 75.75% to $1.2 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $1.2 million, $4.8 million, and $1.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.